BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//81qd - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:81qd
X-ORIGINAL-URL:https://www.81qd.com
X-WR-CALDESC:Events for 81qd
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260914
DTEND;VALUE=DATE:20260918
DTSTAMP:20260828T185526Z
CREATED:20260806T172538Z
LAST-MODIFIED:20260828T185526Z
UID:1498-1789344000-1789689599@www.81qd.com
SUMMARY:81qd at Fierce Pharma Week 2026
DESCRIPTION:How Pharma Teams Turn Clinical Network Data Into Commercial Intelligence\n  \n81qd is sponsoring a Data\, Analytics & Commercial Intelligence Track discussion at Fierce Pharma Week 2026 featuring panelists from Merck. \nThe moderated session will explore how clinical and relationship data can help pharma teams build a more connected view of the stakeholder landscape\, inform commercial planning\, and support more data-driven marketing and engagement decisions. \n\nFeatured Session\nTurning Clinical Network Data Into Commercial Intelligence\nDate: Wednesday\, September 16\nTime: 11:45 AM–12:10 PM ET \nIn this 25-minute discussion\, Susan Abedi of 81qd will moderate a conversation with Merck panelists Shelia Carter\, Associate Director\, HIV Franchise Marketing & Business Operations\, and Kristen Greco\, MBA\, Associate Director\, Cardiovascular Marketing\, on how network analytics can turn clinical and relationship data into commercial intelligence. \nThe discussion will focus on how data can reveal patterns across HCP and stakeholder relationships\, support audience prioritization and footprint expansion\, and inform more data-driven marketing and engagement decisions. \n\nWhat Attendees Will Learn\n\nUnderstand how clinical and relationship data can help teams build a more connected view of the HCP and stakeholder landscape\nLearn how network analytics can reveal patterns that inform customer planning\, audience prioritization\, and footprint expansion\nExplore how commercial teams can translate network insights into more data-driven marketing and HCP engagement decisions\nDiscuss how network analysis helped identify a new engagement KPI tied to marketing and commercial objectives\n\nPanelists\n\nSusan Abedi\, Chief Strategy Officer\, 81qd\nShelia Carter\, Associate Director\, HIV Franchise Marketing & Business Operations\, Merck\nKristen Greco\, MBA\, Associate Director\, Cardiovascular Marketing\, Merck\n\n\nMeet 81qd at Fierce Pharma Week\nInterested in learning how clinical network data and network analytics can support more informed commercial planning and HCP engagement strategy? \nConnect with 81qd at Fierce Pharma Week 2026 to discuss how data-driven insights can help your team identify stakeholder relationships\, engagement opportunities\, and new ways to measure impact. \nRequest a meeting
URL:https://www.81qd.com/event/81qd-at-fierce-pharma-week-2026/
LOCATION:Pennsylvania Convention Center\, Philadelphia\, PA
ATTACH;FMTTYPE=image/png:https://www.81qd.com/wp-content/uploads/fpw2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261015
DTSTAMP:20260921T162654Z
CREATED:20260806T183914Z
LAST-MODIFIED:20260921T162654Z
UID:1510-1791849600-1792022399@www.81qd.com
SUMMARY:81qd at the TLL Engagement Summit Philadelphia 2026
DESCRIPTION:Elevating the TLL Toolkit: Content That Enables More Meaningful KOL Engagement\n81qd is proud to sponsor the 7th TLL Engagement Summit in Philadelphia\, taking place October 13–14\, 2026. Join us for a featured panel exploring how the right content can equip TLLs for more relevant\, valuable\, and engaging interactions with KOLs. \nAbout the Session\nContent is a critical enabler of meaningful TLL interactions with KOLs\, but what does effective TLL content actually look like? \nThis panel will explore the role content plays in supporting KOL engagement\, from defining the right content categories and development considerations to navigating review\, common pitfalls\, and practical watchouts. Panelists will share perspectives and best practices for developing resources that help TLLs deliver greater value in their KOL interactions. \nWhat Attendees Will Learn\n\nWhich types of content best support meaningful TLL and KOL interactions\nHow to develop resources that reflect the needs of both TLLs and KOLs\nKey considerations for content development and review\nCommon pitfalls that can limit the usefulness of TLL materials\n\nModerator\nSusan Abedi\, Chief Strategy Officer\, 81qd \nPanelists\nJennifer Zumoff\, National Director\, Thought Leader Liaisons\, Neuroscience\, Johnson & Johnson \nClaire Finn\, PhD\, Sr. Vice President\, Medical\, Synapse Medical Communications \n\nTLL Engagement Summit Philadelphia\nDate: October 13–14\, 2026Location: Philadelphia\, PA \n\nMeet 81qd in Philadelphia\nConnect with 81qd at the TLL Engagement Summit to explore how data\, analytics\, and network intelligence can support thought leader identification\, stakeholder planning\, and more informed engagement strategies. \n\nRequest a Meeting
URL:https://www.81qd.com/event/81qd-at-the-tll-engagement-summit-philadelphia-2026/
LOCATION:Convene\, 2001 Market Street\, Philadelphia\, PA\, 19103\, United States
ORGANIZER;CN="Momentum Events":MAILTO:info@momentumevents.com
END:VEVENT
END:VCALENDAR